Literature DB >> 34314349

The level of carbon dioxide is the determinant of successful noninvasive ventilation pressure titration in patients with nonhypercapnic primary central sleep apnea: a case report.

Xuejiao Han1, Dan Zhao1, Jianqing Wang1, Yan Wang1, Lixia Dong1, Bao-Yuan Chen1.   

Abstract

Primary central sleep apnea is classified as nonhypercapnic central sleep apnea. High loop gain, lower CO2 reserves, and other reasons can lead to hypocapnia in patients who develop intermittent hyperventilation during sleep. Therefore, it is necessary to monitor nocturnal CO2 level for these patients. We report a female patient diagnosed with nonhypercapnic primary central sleep apnea who complained of snoring, apnea, and excessive daytime sleepiness. With the monitoring of transcutaneous partial pressure of CO2, manual noninvasive ventilation pressure titration was performed with continuous positive airway pressure, bilevel positive airway pressure in a spontaneous-timed mode, and adaptive servo-ventilation mode for 3 nights, respectively. Only adaptive servo-ventilation mode could stabilize the transcutaneous partial pressure of CO2 above the apneic threshold (approximately 40 mm Hg) with successfully eliminating central apnea events. It is concluded that the level of CO2 is the determinant of successful noninvasive ventilation pressure titration in patients with nonhypercapnic central sleep apnea. CITATION: Han X, Zhao D, Wang J, Wang Y, Dong L, Chen B-y. The level of carbon dioxide is the determinant of successful noninvasive ventilation pressure titration in patients with nonhypercapnic primary central sleep apnea: a case report. J Clin Sleep Med. 2022;18(1):319-324.
© 2022 American Academy of Sleep Medicine.

Entities:  

Keywords:  adaptive servo-ventilation; apneic threshold; central sleep apnea; loop gain; non-hypercapnic; transcutaneous partial pressure of carbon dioxide

Mesh:

Substances:

Year:  2022        PMID: 34314349      PMCID: PMC8807922          DOI: 10.5664/jcsm.9568

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  11 in total

Review 1.  Sleep-disordered Breathing in Neuromuscular Disease.

Authors:  Loutfi S Aboussouan
Journal:  Am J Respir Crit Care Med       Date:  2015-05-01       Impact factor: 21.405

2.  Crossing the apnoeic threshold: causes and consequences.

Authors:  Jerome A Dempsey
Journal:  Exp Physiol       Date:  2004-11-30       Impact factor: 2.969

Review 3.  What is the Optimal Strategy for Adaptive Servo-Ventilation Therapy?

Authors:  Teruhiko Imamura; Koichiro Kinugawa
Journal:  Int Heart J       Date:  2018-05-23       Impact factor: 1.862

4.  Loop gain in apnea: gaining control or controlling the gain?

Authors:  Matthew T Naughton
Journal:  Am J Respir Crit Care Med       Date:  2010-01-15       Impact factor: 21.405

Review 5.  Central sleep apnoea-a clinical review.

Authors:  Rexford T Muza
Journal:  J Thorac Dis       Date:  2015-05       Impact factor: 2.895

Review 6.  Pathogenesis of central and complex sleep apnoea.

Authors:  Jeremy E Orr; Atul Malhotra; Scott A Sands
Journal:  Respirology       Date:  2016-10-31       Impact factor: 6.424

7.  The determinants of the apnea threshold during NREM sleep in normal subjects.

Authors:  James A Rowley; Xusong S Zhou; Michael P Diamond; M Safwan Badr
Journal:  Sleep       Date:  2006-01       Impact factor: 5.849

Review 8.  Sleep-Disordered Breathing in Neuromuscular Disease: Diagnostic and Therapeutic Challenges.

Authors:  Loutfi S Aboussouan; Eduardo Mireles-Cabodevila
Journal:  Chest       Date:  2017-03-31       Impact factor: 9.410

Review 9.  How important is the CO2 chemoreflex for the control of breathing? Environmental and evolutionary considerations.

Authors:  Joseph M Santin
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2017-09-29       Impact factor: 2.320

10.  Adaptive servoventilation improves cardiac function and respiratory stability.

Authors:  Olaf Oldenburg; Thomas Bitter; Roman Lehmann; Stefan Korte; Zisis Dimitriadis; Lothar Faber; Anke Schmidt; Nina Westerheide; Dieter Horstkotte
Journal:  Clin Res Cardiol       Date:  2010-09-12       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.